Top compounds associated with response to USP17L29


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.03 0.4
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.03 0.4
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.048 0.4
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.039 0.4
mRNA UNC0638 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA CIL70 CTRPv2 pan-cancer AAC 0.039 0.4
Download CSV